BioP2P’s Matt Gardner to Speak at SynBioBeta Global Synthetic Biology Conference

SAN JOSE, Calif., April 30, 2024 (GLOBE NEWSWIRE) — Matt Gardner, Board President of the California Biomanufacturing Center and Chair of the BioProcess to Product Network (BioP2P), is scheduled to speak at the 2024 SynBioBeta Global Biology Conference. Gardner’s Lightning Talk titled “Seeing Alternative Investors as Growth Partners” will take place at 11 a.m. on […]

NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant

WILMINGTON, Del., March 11, 2024 (GLOBE NEWSWIRE) — The U.S. Patent and Trademark Office has issued a patent, US11920140, for the use of CRISPR technologies to edit organellar genomes to NAPIGEN, Inc., a biotechnology company that specializes in mitochondrial and chloroplast genome engineering. Read the full release.

Levine Media Group Launches Life Sciences D’n’A Video Podcast

Levine Media Groups has launched the Life Sciences D’n’A podcast, a video podcast that explores data analytics and AI in the life sciences. It  is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and […]

Global Genes Releases NEXT Report 2024: Rewriting the Rules

Despite a difficult financing environment, the rare disease sector made significant advances with a sharp increase in the approval of new medicines, which included the first CRISPR Cas9 gene editing therapy for sickle cell disease, the first gene therapies for hemophilia A and Duchenne muscular dystrophy, and the first redosable gene therapy for dystrophic epidermolysis […]